Qube Research & Technologies (QRT)
FHTX icon

Qube Research & Technologies (QRT)’s Foghorn Therapeutics FHTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$992K Buy
203,296
+122,018
+150% +$541K ﹤0.01% 2417
2026
Q1 		$389K Buy
81,278
+28,021
+53% +$154K ﹤0.01% 2802
2025
Q4 		$288K Buy
+53,257
New +$241K ﹤0.01% 2959
2025
Q2 		– Sell
-51,098
Closed -$187K – 3669
2025
Q1 		$187K Buy
51,098
+1,455
+3% +$6.63K ﹤0.01% 2891
2024
Q4 		$234K Buy
49,643
+29,094
+142% +$212K ﹤0.01% 2792
2024
Q3 		$191K Buy
+20,549
New +$149K ﹤0.01% 2600

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FHTX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Foghorn Therapeutics (FHTX) stake by 150% in Q2 2026, buying an estimated $541K and bringing the position to 203,296 shares worth $992K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Qube Research & Technologies (QRT) first reported a position in FHTX in Q3 2024 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 203,296 shares of Foghorn Therapeutics worth $992K as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 122,018 Foghorn Therapeutics shares in Q2 2026, an estimated $541K.
  • Foghorn Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2417 holding.
  • Qube Research & Technologies (QRT) first reported a position in Foghorn Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.